Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Project 1 (includes a skin biopsy component):
- People diagnosed with a type of high blood pressure affecting the lungs (either idiopathic, heritable, or associated with another condition), or family members of someone with one of these diagnoses
- People aged 0 to 90 years old (for the skin biopsy part, people aged 12 to 90 years old)
Project 2 (includes blood collection and other testing):
- People diagnosed with a type of high blood pressure affecting the lungs (either idiopathic, heritable, or associated with another condition), or family members of someone with one of these diagnoses
- People aged 0 to 90 years old
- People who can reasonably travel to the clinic for blood collection and other tests
- People who are able to go without food for a period of time before sample collection and a blood vessel function test
Project 3:
- People diagnosed with a type of high blood pressure affecting the lungs (either idiopathic, heritable, or associated with another condition), or family members of someone with one of these diagnoses
- People aged 7 to 90 years old
Who may not be able to join:
Project 1:
- People with a different diagnosis not listed above
- People older than 90 years old (or, for the skin biopsy part, people younger than 12 or older than 90)
Project 2:
- People with a different diagnosis not listed above
- People who have significant difficulty travelling to the clinic for blood collection and other tests
- People who are unable to go without food before sample collection and testing
Project 3:
- People with a different diagnosis not listed above
- People younger than 7 or older than 90 years old
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: James E Loyd, MD, Vanderbilt University Medical Center
Phone: 800-288-0378
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ratio of sex hormone metabolites; Evaluation of insulin resistance in pulmonary arterial hypertension patients/Clinical trial of Metformin in Pulmonary Arterial Hypertension; Mechanism, safety, and efficacy of ACE-2 (Angiotensin Converting Enzyme 2) in the treatment of PAH.; Clinical Trial of Metformin in Pulmonary Arterial Hypertension
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.